Spanning four continents and enrolling hundreds of people, a new clinical trial will test the effectiveness of two anti-inflammatory medicines as potential treatments for long COVID, scientists from ...

A research note published yesterday by Edison Investment Research reinforced the strategy behind Recce Pharmaceuticals Ltd’s ...

Ceftazidime and avibactam are two anti-infective drugs that can prove difficult to analyze in serum. Determining them can ...

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the ...